UnknownNot Applicable

The Use of Virtual Reality for the Treatment of Visual Vertigo.

United Kingdom18 participantsStarted 2017-01

Plain-language summary

This study investigates the use of virtual environments presented on a head mounted display for the rehabilitation of those suffering with visual vertigo. The control group and treatment groups will be presented with two different sets of environments and be given the same head and eye exercises to complete within the environment. They will also be provided with at home exercises to complete.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Those who have been diagnosed with visual vertigo and have scored a significant level on the Situational Characteristic Questionnaire (over 0.74 as per Pavlou et al., 2006). Exclusion Criteria: * Those with or under investigation for epilepsy. * Those who have been determined to have no or limited balance function in both ears. * Those with reduced visual acuity that will leave them unable to view the 3D effects of the head mounted display. * Those with severe mental health disorders e.g. psychosis, paranoid disorders, bipolar disorder or a history of substance abuse. * Severe neck pain/ restricted movement. * Previous treatment for visual vertigo. * Those with an fluctuating vestibular disorder such as Ménière's disease or vestibular migraine. * Those with untreated Benign Paroxymal Positional Vertigo (BPPV). * Those with a significant brain injury, or head injury that results in a central vestibular disorder. * Those with an arrhythmia.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in scoring on the Situational Characteristic Questionnaire

Timeframe: Week 1 and Week 6

Trial details

NCT IDNCT03020654

SponsorSheffield Teaching Hospitals NHS Foundation Trust

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-11

Contact for this trial

Kirsty M Walker, BSc

011427112131 kirsty.walker@sth.nhs.uk

View on ClinicalTrials.gov More Treatment of Visual Vertigo trials